Genetics
Home › Medical research › IBS & ulcerative colitis
Insufficient evidence

IBS & ulcerative colitis & cannabis

Effectiveness and safety remain uncertain. Trials in ulcerative colitis showed improved patient-reported quality of life but no objective (endoscopic) remission, and IBS has essentially no controlled trial evidence.

Sources: UC RCT (PLOS ONE)

Most-studied cannabinoids

THCCBD

Safety & cautions

Symptom relief does not equal disease control; hyperemesis risk with heavy use.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.